Ozempic, Wegovy, other GLP-1RA drugs not linked to increased pancreatic cancer risk, study finds
Posted:
New research has concluded that drugs from the glucagon-like peptide-1 receptor agonists (GLP-1RA) class do not increase the risk of pancreatic cancer.
At GIANT Health Event #GIANT2025, meet with exhibitor Cineon to discuss ELE-Stress - an immersive resource hub developed with Torbay & South Devon NHS Foundation Trust and the University of Bath.
Powered by Cineon’s Empathic Learning Engine (ELE), it offers:
Adaptive,…
AI-Powered Nutrition: The Future of Preventive Health
Meet Dr. Maria Kardakova, Founder & CEO of iCook Health, at the GIANT Health Conference 2025. A Registered Nutritionist and PhD in Biosciences & Medicine, Maria is pioneering the integration of AI, biomarkers,…
Attendees
Sponsors and Exhibitors
Agenda 2025
Contact us